Zydus Wellness Ltd-$ share price
Zydus Wellness Ltd-$ (ZYDUSWELL) is a stock listed on India's exchanges (NSE & BSE). On Traddx you can view its live price, interactive candlestick charts with 20/50/200-day moving averages and golden/death-cross detection, quarterly results, analyst price targets, peer comparison, and the smart-money signal — which star investors hold it and who is buying it on today's bulk/block deals tape.
Zydus Wellness Limited value chain — customers, suppliers & competitors
Zydus Wellness makes and sells health and wellness products like Sugar Free, Everyuth, and Nutralite, sitting between raw material providers and end-consumers buying through stores.
🛒 Customers — who buys from Zydus Wellness Limited
- Modern Retail Chains — Packaged consumer goods
- General Trade Distributors — Health and wellness products
- E-commerce Platforms — Sugar Free, Everyuth, and Nutralite products
⛓️ Suppliers — raw materials & inputs
- Packaging Material Suppliers — Cartons, plastic bottles, and flexible packaging
- Agro-Commodity Suppliers — Raw food ingredients like oils and sweeteners
- Active Ingredient Suppliers — Skincare formulation chemicals for Everyuth
⚔️ Competitors — other sellers
- Nestle India Limited — Competes in packaged foods and nutrition, with a much larger market size.
- Hindustan Unilever Limited — Major rival in the personal care segment through brands like Lakme and Glow & Lovely.
- Marico Limited — Competes in health foods and personal care categories.
🔀 Other suppliers to its customers
- Hindustan Unilever Limited — Supplies competing personal care and food items to the same retailers.
- ITC Limited — Provides alternative packaged foods and personal care goods to retailers.
🤝 Peers that share its suppliers
- Dabur India Limited — Buys similar packaging materials and natural ingredients for wellness products.
- Marico Limited — Sources similar packaging and agricultural inputs for consumer goods.
This value-chain map is AI-researched from public sources; company links and any figures are estimates, not official company disclosures. Not investment advice.